Tyra Biosciences Reports Third Quarter 2025 Financial Results and Highlights

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...

Rhythm Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Update

Third quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $51.3 million -- -- December 20, ...